Atlas Trials

Pre-market Study of the DREAMS 2G Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-III)

Clinical trial NCT02716220 · COMPLETED

Trial details

NCT number
NCT02716220
Sponsor
Biotronik AG
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery DiseaseCoronary Artery Stenosis
Start date
2016-03-01
Primary completion
2017-12-01
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.